Sellas Life Sciences Stock Return On Asset
SLS Stock | USD 1.17 0.05 4.10% |
Sellas Life Sciences fundamentals help investors to digest information that contributes to Sellas Life's financial success or failures. It also enables traders to predict the movement of Sellas Stock. The fundamental analysis module provides a way to measure Sellas Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sellas Life stock.
Return On Assets is likely to drop to -6.3 in 2024. Sellas | Return On Asset |
Sellas Life Sciences Company Return On Asset Analysis
Sellas Life's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Sellas Life Return On Asset | -1.29 |
Most of Sellas Life's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sellas Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Sellas Return On Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Sellas Life is extremely important. It helps to project a fair market value of Sellas Stock properly, considering its historical fundamentals such as Return On Asset. Since Sellas Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sellas Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sellas Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition |
Sellas Total Assets
Total Assets |
|
Based on the latest financial disclosure, Sellas Life Sciences has a Return On Asset of -1.2915. This is 85.24% lower than that of the Biotechnology sector and 94.53% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Sellas Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sellas Life's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sellas Life could also be used in its relative valuation, which is a method of valuing Sellas Life by comparing valuation metrics of similar companies.Sellas Life is currently under evaluation in return on asset category among its peers.
Sellas Fundamentals
Return On Equity | -8.88 | ||||
Return On Asset | -1.29 | ||||
Current Valuation | 61.89 M | ||||
Shares Outstanding | 70.38 M | ||||
Shares Owned By Insiders | 0.24 % | ||||
Shares Owned By Institutions | 7.36 % | ||||
Number Of Shares Shorted | 8.61 M | ||||
Price To Book | 5.18 X | ||||
Price To Sales | 26.90 X | ||||
Gross Profit | 900 K | ||||
EBITDA | 529 K | ||||
Net Income | (37.34 M) | ||||
Cash And Equivalents | 26.99 M | ||||
Cash Per Share | 1.31 X | ||||
Total Debt | 906 K | ||||
Debt To Equity | 0.06 % | ||||
Current Ratio | 2.36 X | ||||
Book Value Per Share | (0.25) X | ||||
Cash Flow From Operations | (31.41 M) | ||||
Short Ratio | 14.07 X | ||||
Earnings Per Share | (0.67) X | ||||
Target Price | 5.83 | ||||
Number Of Employees | 16 | ||||
Beta | 2.4 | ||||
Market Capitalization | 82.35 M | ||||
Total Asset | 6.22 M | ||||
Retained Earnings | (217.24 M) | ||||
Working Capital | (10.56 M) | ||||
Net Asset | 6.22 M |
About Sellas Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sellas Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sellas Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sellas Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.